Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Neoplastic Cells, Circulating 2Colorectal Neoplasms 2Neoplasms 1Neoplasm, Residual 1Colonic Neoplasms 1

Interventions

Blood Specimen Collection 29Reverse Transcriptase Polymerase Chain Reaction 7Flow Cytometry 7Surgical Procedures, Operative 4Liquid Biopsy 4cabazitaxel 3Trastuzumab 3Propofol 3Carboplatin 3Bevacizumab 3Standard of Care 2Spinal Puncture 2Sevoflurane 2Positron Emission Tomography Computed Tomography 2Pirinitramide 2Neoadjuvant Therapy 2Morphine 2Laparoscopy 2Hematologic Tests 2Gemcitabine 2Folfox protocol 2Epirubicin 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Cisplatin 2Cetuximab 2Capecitabine 2Aspirin 2Anesthesia, General 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplastic Cells, Circulating × Pirinitramide × Clear all
NCT03700411 2023-12-07

POACC-1

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
125 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT03700541 2023-12-07

POACC-2

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
71 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡